Research On Tax Policy To Promote The Development Of Pharmaceutical Manufacturing Industry In China

In October 2016,the State Council issued the “Health China 2030 Plan”,which emphasized the importance of the development of pharmaceutical manufacturing industry.In recent years,although the growth rate of the pharmaceutical manufacturing industry has slowed down,it still keeps the momentum of growth.The development of the pharmaceutical manufacturing industry plays an increasingly important role in prospering the national economy,promoting scientific and technological innovation,and safeguarding people's health and happiness.However,compared with the global pharmaceutical manufacturing industry,the innovation capacity and sales volume of China's pharmaceutical manufacturing industry are still far behind those of developed countries.In addition,the pharmaceutical manufacturing industry is related to the life and death of people.How to promote the industrial upgrading and development of China's pharmaceutical manufacturing industry has attracted much attention from our country.Taxation,as one of the national macro-control policies,will inevitably affects the development of the pharmaceutical manufacturing industry.Therefore,the government should give more support to the pharmaceutical manufacturing industry and optimize the tax policy to promote the innovation and development of the pharmaceutical manufacturing industry.Here are the four chapters of this article.Chapter 1: Introduction.This chapter first introduces the research background and significance,sorting out the relevant domestic and foreign literature,and then introduces the research method,framework,possible innovation points and deficiencies of this paper.Chapter 2: Economic Analysis.This chapter first expounds the general analysis of the development of pharmaceutical manufacturing industry,clarifies the concept,industrial chain and characteristics of pharmaceutical manufacturing industry,selects the influencing factors and evaluation indexes of the development of pharmaceutical manufacturing industry,and then studies the influence of tax policy on the development of pharmaceutical manufacturing industry by using economic model and mathematical deduction.Chapter 3: Empirical Analysis.This chapter firstly sorts out the development process of tax policy of pharmaceutical manufacturing industry.Then,the change trend of tax burden of pharmaceutical manufacturing industry is analyzed.Finally,using principal component analysis,constructs Seemingly Unrelated Regression to explore the impact of tax burden change on the development ability of pharmaceutical manufacturing industry.Chapter 4: Policy Suggestions for promoting the development of pharmaceutical manufacturing industry.Following the principles of tax fairness,efficiency and moderation,this paper proposes the optimal path of tax policy for pharmaceutical manufacturing industry from two aspects of reducing the tax burden of turnover tax and corporate income tax.In terms of turnover tax,it is suggested to expand the scope of zero tariff on imported raw materials,reduce the VAT rate,optimize the deduction standard of input tax,and expand the types of drugs exempted from VAT.In the aspect of corporate income tax,it is suggested to improve the scope of corporate income tax preference,implement the tax reduction and exemption policy in the research and development stage,and moderately increase the standard of pre-tax deduction of corporate income tax.